Thus, cetuximab and 47Sc-conjugated cetuximab promote genetic instability by inhibiting inappropriate DNA repair processes through the suppression of DNA-PK activity, leading to cell death in EGFR-overexpressing NSCLC cells. Here, EGFR is linked to non-small cell lung carcinoma.